other material
confidence high
sentiment neutral
materiality 0.25
Vera Therapeutics stockholders elect three Class II directors, ratify KPMG, approve say-on-pay
Vera Therapeutics, Inc.
- Michael M. Morrisey elected with 45.3M For, 13.8M Withheld; Patrick G. Enright with 54.7M For; James R. Meyers with 58.9M For.
- Ratification of KPMG as auditor for FY 2026 approved (61.8M For, 44.7K Against, 87.3K Abstain).
- Advisory vote on executive compensation approved (56.6M For, 2.4M Against, 84.3K Abstain, 2.9M Broker non-votes).
- 71.7M shares outstanding and entitled to vote as of record date March 24, 2026.